Medicilon USA Corp.

Medicilon USA Corp.

Medicilon is a leading CRO company that provides comprehensive drug R&D services on a global scale. From drug discovery, pharmaceutical research to preclinical research, Medicilon has supported more than 2000 client R&D programs worldwide resulting in 520+ IND filings. With proven scientific excellence and FDA-aligned methodologies, we help biotech and pharmaceutical innovators fast-track their path from discovery to IND success.

In addition, Medicilon offers attractive large animal models (non-human primates, dogs, rabbits, and miniature pigs), tumor & non-tumor animal models (including Xenograft models, PDX / PDXO models), and support for simultaneous China-U.S. IND filing to streamline global drug development and approval.

Medicilon leverages 20+ years of integrated preclinical expertise to accelerate drug discovery and development from target engagement through IND submission. With scalable chemistry, advanced biology platforms (AOCs, PROTACs, ADCs, CAR-T, mRNA display), and GLP- compliant pharmacology, DMPK, and toxicology, we provide seamless workflows to reduce development risk and timelines. This session highlights case studies and lessons from supporting global biotech and pharma programs.

Acute Toxicology Services/Testing, Animal Models, CRO—Contract Research Organization, GLP—Good Laboratory Practice Services, Research, Toxicokinetics